Citations

Clear

3042 citation(s) found for "Kumar, S".

Coronary Microvascular Dysfunction in Cardiovascular Disease: Diagnosis and Management
Ahmad, Rimsha , Niaz, Mahnoor, Khan, Saifullah , Frangaj, Kristjana , Kumar, Mahesh, Basha, Nabel Rajab , Hussain, Syed Sadam, Chettri, Sunit, Maheta, Darshilkumar, Frishman, William, Aronow, Wilbert S., Kumar, Mahesh, Maheta, Darshilkumar, Frishman, William, Aronow, Wilbert S.

Mayo Clinic

Cardiology in Review | January 26, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/crd.0000000000001188 | PMID 41582311 Get It

Coronary microvascular dysfunction (CMD) is increasingly recognized as a central mechanism underlying myocardial ischemia, heart failure with preserved ejection fraction, and adverse cardiovascular outcomes in patients with and without obstructive coronary artery disease. The coronary microcirculation plays a critical role in regulating myocardial perfusion through tightly coordinated myogenic, metabolic, and endothelial pathways. Disruption of these mechanisms results in impaired vasodilatory capacity, abnormal coronary flow reserve, and microvascular ischemia. This review summarizes the anatomy and physiology of coronary microcirculation and examines the pathophysiologic mechanisms driving CMD, including endothelial dysfunction, structural remodeling, inflammation, and neurohormonal dysregulation. Contemporary diagnostic strategies are reviewed, with emphasis on invasive coronary function testing and advanced noninvasive imaging modalities such as positron emission tomography and cardiac magnetic resonance imaging. The clinical implications of CMD across diverse disease states, including ischemia with nonobstructive coronary arteries, heart failure, and cardiomyopathies, are discussed. Finally, current therapeutic approaches, prognostic considerations, and emerging research directions aimed at improving diagnosis and targeted treatment of CMD are highlighted.
Temporal Trends in Mortality from Hairy Cell Leukemia in the United States: Evidence from SEER Registries
Mal, Madho, Keswani, Shiwani, Tummala, Nayanika, Amin, Faiqa, Alhusari, Leena, Kumar, Love, Kumar, Love

Mayo Clinic

International Journal of Cancer Care and Delivery | January 26, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.53876/001a.129664 Get It

Association of standard postoperative day 1 discharge following endonasal surgery for pituitary adenoma with lower complication rates and unplanned medical care
Rindler, Rima S. , Dang, Danielle , Kumar, Rahul, Erickson, Dana, Davidge‐Pitts, Caroline , Bancos, Irina, Choby, Garret M., Atkinson, John, Herndon, Justine , Erickson, Dana , Bancos, Irina , Choby, Garret , Atkinson, John L. D., Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurosurgery | January 24, 2026 | Volume: 144 | Issue: 4 | Pages: 929-936

10.3171/2025.9.jns25752 | PMID 41576384 Get It

OBJECTIVE Early discharge following uncomplicated endonasal resection of pituitary adenoma has been described as safe and feasible. Discharge on postoperative day (POD) 1 is not a widely implemented practice in the United States. This study aimed to evaluate the safety of routine POD1 discharges by assessing postoperative unplanned medical care rates compared with those of patients discharged on POD 2 or later (POD2+). The secondary endpoint was to identify predictors of delayed discharge in the POD2+ cohort. METHODS A retrospective database review of the medical records of 534 patients who underwent endonasal resection of pituitary adenoma at the Mayo Clinic was performed. Relevant demographics, tumor characteristics, and perioperative metrics were abstracted from the medical record, including intraoperative CSF leakage, postoperative complications, emergency department visits, or inpatient readmissions within 30 days. Descriptive, univariate, and multivariate analyses were performed. RESULTS In comparison to 422 (79%) patients discharged on POD1, 112 (21%) patients discharged on POD2+ had a higher unplanned medical care rate (13% vs 5.5%, p = 0.019). There were significantly more men in the POD1 group (48%) than in the POD2+ group (37%) (p < 0.04). The most common reasons for POD1 unplanned care were endocrine dysfunction (2.4%), split evenly between syndrome of inappropriate antidiuretic hormone and adrenal insufficiency, whereas the most frequent reason in the POD2+ cohort was medical (0.06%). Univariate analyses indicated that female sex, higher BMI, intensive care unit (ICU) admission, obstructive sleep apnea, continuous positive airway pressure dependence, intraoperative CSF leakage, and diabetes insipidus (DI) increased the likelihood of POD2+ discharge. The reduced logistic regression model demonstrated a higher likelihood of POD2+ discharge with older age, ICU admission, intraoperative CSF leakage, and DI (p < 0.001). Common factors contributing to discharge after POD1 included endocrine (n = 66, 35%) and/or medical (n = 65, 34%) reasons. CONCLUSIONS Routine patient discharge on POD1 following uncomplicated endonasal resection of pituitary adenoma is a safe practice, as evidenced by the significantly lower rates of unplanned medical care and complications compared with those of patients discharged on POD2 or later. Delayed discharge was associated with older age, ICU admission, intraoperative CSF leakage, and DI. The most frequent reasons for POD1 readmission were endocrine versus medical reasons for POD2+. Preoperative identification of risk factors for delayed discharge and preemptive management of endocrine and medical complications may reduce the length of stay and return to medical care.
Predictors of achieving Neck Disability Index minimum clinically important difference following cervical deformity surgery
Mikula, Anthony L., Scheer, Justin K., Turner, Jay D., Lafage, Renaud, Lafage, Virginie, Kebaish, Khaled , Klineberg, Eric O., Mundis, Gregory M., Daniels, Alan H., Eastlack, Robert K. , Lewis, Stephen M., Protopsaltis, Themistocles S., Soroceanu, Alex, Gupta, Munish C., Kim, Han Jo, Kelly, Michael P., Lenke, Lawrence G., Shaffrey, Christopher I., Bess, Shay R., Smith, Justin S., Ames, Christopher P., Mikula, Anthony L. , Scheer, Justin K. , Kumar, Rahul Robaish , Turner, Jay D. , Mullin, Jeffrey P. , Lafage, Renaud , Lafage, Virginie , Kebaish, Khaled M. , Klineberg, Eric O. , Mundis, Gregory M. , Daniels, Alan H. , Lewis, Stephen M., Protopsaltis, Themistocles S. , Gupta, Munish C , Kim, Han Jo , Kelly, Michael P. , Lenke, Lawrence G. , Shaffrey, Christopher I. , Bess, Shay R. , Smith, Justin S. , Ames, Christopher Pearson

Mayo Clinic

Journal of Neurosurgery: Spine | January 22, 2026 | Volume: 44 | Issue: 4 | Pages: 581-588

10.3171/2025.9.spine25668 | PMID 41569694 Get It

OBJECTIVE The aim of this study was to determine predictors of the minimum clinically important difference (MCID) in the Neck Disability Index (NDI) following cervical spinal deformity surgery. METHODS A retrospective review was performed of a prospective, multicenter adult cervical spinal deformity database. All patients had baseline and 1-year NDI scores. Patients met MCID with an improvement of NDI by 7 points between baseline and 1 year, as previously established. Baseline demographics, comorbidities, and both baseline and 1-year spinopelvic parameters were evaluated for statistical significance in a univariate logistic regression analysis. Significant variables, in addition to baseline NDI, were analyzed in a multivariable logistic regression model by backward selection with Akaike information criterion minimization. RESULTS A total of 122 patients were included with a median age of 62 (IQR 56, 69) years; 62% of patients were female. Of the 122 patients, 72 (59%) achieved NDI MCID at 1 year. Predictors of achieving MCID on univariate analysis included a lower Charlson Comorbidity Index (CCI) total score (OR 0.70, p = 0.03), depression as a comorbidity (OR 2.9, p = 0.02), lower C2 tilt at the 1-year follow-up (OR 0.92, p = 0.02), and a greater difference between 1-year postoperative C2–7 sagittal vertical axis (SVA) and preoperative C2–7 SVA (OR 0.98, p = 0.0495). On multivariable logistic regression analysis, predictors of achieving MCID included a lower CCI (OR 0.62, p = 0.03), depression as a comorbidity (OR 3.1, p = 0.059), a greater change in C2–7 SVA at the 1-year follow-up compared with baseline (OR 0.97, p = 0.055), and baseline NDI (OR 1.02, p = 0.24) with an area under the curve of 0.74. CONCLUSIONS The best-fit multivariable model included higher baseline NDI, a greater change in C2–7 SVA, patient-reported baseline depression, and lower CCI as important factors in predicting NDI MCID.
Coronary Artery Spasm: Pathophysiology, Diagnosis, and Clinical Implications
Ahmad, Rimsha , Khan, Saifullah , Kumar, Mahesh, Niaz, Mahnoor, Basha, Nabel Rajab , Hussain, Syed Sadam, Frangaj, Kristjana , Chettri, Sunit, Maheta, Darshilkumar, Frishman, William, Aronow, Wilbert S., Maheta, Darshilkumar, Aronow, Wilbert S.

Mayo Clinic

Cardiology in Review | January 21, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/crd.0000000000001187 | PMID 41563117 Get It

Coronary artery spasm (CAS) is a dynamic vasomotor disorder characterized by transient, intense constriction of epicardial coronary arteries, leading to myocardial ischemia in patients with and without obstructive coronary artery disease. CAS plays a central role in vasospastic angina, ischemia with nonobstructive coronary arteries and myocardial infarction with nonobstructive coronary arteries, malignant arrhythmias, and sudden cardiac death. Its pathophysiology is multifactorial, involving endothelial dysfunction, vascular smooth muscle hyperreactivity, inflammation, oxidative stress, autonomic imbalance, and genetic susceptibility, with notable ethnic and sex-related differences. Diagnosis relies on integration of clinical features, electrocardiographic changes, and invasive coronary provocation testing using acetylcholine or ergonovine, supported by advanced imaging and functional assessment when microvascular involvement is suspected. Management is centered on calcium channel blockers and nitrates, aggressive risk factor modification, particularly smoking cessation, and individualized strategies for refractory or high-risk patients. Improved recognition and standardized diagnostic pathways are essential to optimize outcomes and reduce life-threatening complications associated with CAS.
Shock: Pathophysiology, Classification, and the Role of Lactate in Diagnosis and Prognosis
Ahmad, Rimsha , Basha, Nabel Rajab , Kumar, Mahesh, Niaz, Mahnoor, Khan, Saifullah , Chettri, Sunit, Frangaj, Kristjana , Hussain, Syed Sadam, Arslan, Fatima Safi , Frishman, William H., Aronow, Wilbert S., Frishman, William H. , Aronow, Wilbert S.

Mayo Clinic

Cardiology in Review | January 21, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/crd.0000000000001189 | PMID 41563115 Get It

Shock is a life-threatening state of circulatory failure characterized by inadequate tissue oxygen delivery and cellular hypoxia. Lactate has emerged as a central biomarker in the diagnosis, risk stratification, and management of shock, yet its interpretation is complex and context dependent. Although traditionally viewed as a marker of anaerobic metabolism and tissue hypoperfusion, hyperlactatemia in distributive shock, particularly sepsis, frequently reflects multifactorial mechanisms, including increased aerobic glycolysis, adrenergic stimulation, mitochondrial dysfunction, and impaired hepatic clearance. This review examines the pathophysiology and classification of shock, the biochemical basis of lactate production and clearance, and the prognostic significance of both static lactate levels and lactate kinetics. We synthesize evidence supporting lactate as a robust prognostic marker while highlighting limitations of lactate-targeted resuscitation strategies. Emerging data favor multimodal approaches integrating lactate trends with complementary perfusion markers such as capillary refill time and central venous oxygen saturation. Lactate should be interpreted as one component of a comprehensive physiological assessment rather than an isolated therapeutic target.
Cytogenetics-based Clinical Trajectories in Patients with MRD Negativity Post Autologous Transplant for Multiple Myeloma
Zanwar, Saurabh , Mariotti, E, Kumar, Shaji, Gonsalves, W., Buadi, Francis K. , HAYMAN, Suzanne, Abdallah, N., Binder, Moritz , Cook, Joselle, Dispenzieri, Angela, Dingli, D., Gertz, M., Kourelis, Taxiarchis, Leung, Nelson, Lin, Yi, Siddiqui, Mustaqueem, Go, R., Muchtar, E., Warsame, Rahma, Jevremovic, Dragan, Kyle, RA, Kapoor, Prashant , Rajkumar, S. Vincent, Gonsalves, Wilson I. , Cook, Joselle , Gauto‐Mariotti, Estefania , Gonsalves, Wilson , Binder, Moritz , Buadi, Francis K , Cook, Joselle M , Mariotti, Estefania Gauto , Kumar, Shaji , Hayman, Suzanne R. , Abdallah, Nadine , Dispenzieri, Angela , Dingli, David , Gertz, Morie A. , Kourelis, Taxiarchis , Leung, Nelson , Lin, Yi , Siddiqui, Mustaqeem , Go, Ronald S. , Muchtar, Eli , Warsame, Rahma , Jevremović, Dragan , Kyle, R A, Rajkumar, S. Vincent

Mayo Clinic

No container title available | January 20, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-8586124/v1 Get It

Abstract Measurable residual disease (MRD) assessment has become central to risk-adapted treatment strategies in multiple myeloma, yet the prognostic value of MRD negativity following autologous stem cell transplantation (ASCT) across individual high-risk cytogenetic abnormalities (HRCAs) remains unclear. We analyzed 351 newly diagnosed patients who achieved MRD negativity (sensitivity 2.4×10 − 6 ) at Day 100 following ASCT and had baseline cytogenetic data available. Median follow-up was 50.4 months. Standard-risk cytogenetics were present in 46% (n = 162), while 34% (n = 118) had one HRCA and 20% (n = 71) had ≥ 2 HRCAs. Despite uniform MRD negativity, several HRCAs continued to confer inferior progression-free survival (PFS). Compared with the standard-risk group (4-year PFS 84%), patients with del(17p), 1q21+, t(4;14), or MAF translocations [t(14;16)/t(14;20)] had significantly lower 4-year PFS rates: 56% (HR 2.89; p = 0.0001), 60% (HR 2.46; p = 0.0001), 43% (HR 3.50; p = 0.0001), and 58% (HR 2.51; p = 0.01), respectively. Isolated del(17p) and 1q21 + also conferred inferior PFS. The 4-year PFS was 65% for patients with one HRCA (HR 2.31; p = 0.0004) and 55% for those with ≥ 2 HRCAs (HR 2.75; p = 0.0001). In this large MRD-negative post-ASCT cohort, several HRCAs, including isolated HRCAs, remained clinically meaningful drivers of inferior PFS, highlighting that early MRD negativity does not uniformly mitigate the impact of high-risk biology.
Impact of Kidney Replacement Therapy During Extracorporeal Membrane Oxygenation Support in Terms of Mortality: A Systematic Review and Meta‐Analysis
Sah, Ranjit , Paudel, Amita, Shah, Sangam , Bhattarai, Madhur , Bhandari, Sujata , Adhikari, Bishwa Raj, Sah, Sanjit, Mehta, R., Guru, Pramod, Chaudhary, Sanjay, Sah, Ranjit , Mehta, Rachana , Shah, Sangam , Sah, Sanjit Kumar , Mehta, Rachana , Bhattacharyya, Anirban , Franco, Pablo Moreno , Guru, Pramod , Chaudhary, Sanjay

Mayo Clinic

Health Science Reports | January 20, 2026 | Volume: 9 | Issue: 1 | Pages: No page available

10.1002/hsr2.71742 | PMID 41568124 Get It

ABSTRACT Introduction Extracorporeal membrane oxygenation (ECMO) is a life‐saving intervention for refractory cardiopulmonary failure. Despite advancements reducing complications, ECMO remains associated with acute kidney injury (AKI), often requiring kidney replacement therapy (KRT). Studies report up to 45% of ECMO patients needing KRT, significantly increasing mortality. A prior meta‐analysis suggested a declining mortality trend in recent years. Methodology Following PRISMA guidelines, PubMed, MEDLINE, EMBASE, and Cochrane Library were searched (2000–2024) for randomized and observational studies on adult ECMO patients requiring KRT. Data extraction covered study characteristics, patient demographics, ECMO type, KRT timing, and clinical outcomes. Quality was assessed using the Newcastle–Ottawa Scale. Statistical analyses were performed using RevMan 5.4.1 under a random‐effects model, with mortality as the primary outcome. Result A total of 24 studies (6347 patients) met the inclusion criteria, including 23 observational studies and one RCT. The mean age of ECMO + KRT patients was 51 years in observational studies and 61.2 years in the RCT, with cardiogenic shock as the most common ECMO indication. Meta‐analysis showed a significantly higher mortality in ECMO + KRT patients (RR: 1.86, 95% CI: 1.63–2.12, p < 0.001), with infections and bleeding as key contributors. Subgroup analysis revealed no significant survival difference based on KRT timing, while Veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) was associated with worse outcomes than Veno‐venous extracorporeal membrane oxygenation (VV‐ECMO). The RCT reported 61.9% mortality at 30 days in ECMO + KRT patients. Conclusion KRT during ECMO is associated with increased mortality, likely due to the severity of illness and complications like infections and bleeding. The optimal timing of KRT initiation remains unclear, and no significant survival benefit was found for early KRT. Further large‐scale RCTs are needed to optimize management strategies.
Obesity Phenotyping in Children and Adolescents: Next Steps Towards Precision Medicine in Pediatric Obesity
Saba, Leslie , Acosta, Andres J., Kumar, Seema, Kumar, Seema , Acosta, Andrés , Saba, Leslie , Acosta, Andres , Kelly, Aaron S , Kumar, Seema , Kelly, Aaron S.

Mayo Clinic

Nutrients | January 19, 2026 | Volume: 18 | Issue: 2 | Pages: 303

10.3390/nu18020303 | PMID 41599916 Get It

Pediatric obesity is an increasingly prevalent, chronic, and multifactorial disease. Achieving successful and sustained weight reduction with current interventions remains challenging due to significant heterogeneity in treatment response. This review summarizes current evidence describing variability in outcomes across lifestyle, pharmacologic, and metabolic/bariatric surgery interventions in children and adolescents, and examines key biological, metabolic, behavioral, environmental, and psychosocial factors that influence response. In adults, recent findings on energy balance obesity phenotypes (characterized by abnormal satiation, abnormal postprandial satiety, abnormal hedonic eating, and reduced energy expenditure) have demonstrated promise in predicting weight loss outcomes and guiding tailored interventions. However, data on obesity phenotyping within children and adolescents remain limited. Addressing this gap is essential for advancing precision medicine approaches in pediatric obesity, with the potential to improve treatment selection, enhance effectiveness, and optimize long-term clinical outcomes.
Report from the WPA Section on Positive Psychiatry 2015‐2025
Jeste, Dilip V., Reimers, Karen, Ng, Bernardo , Alessandria, Hernán, Alfonso, César A., Jimenez, Alma L. , Kumar, Manasi, Rabheru, Kiran , Kumar, Manasi , Alarcón, Renato D. , Jeste, Dilip V. , Alfonso, César A., Peseschkian, Hamid

Mayo Clinic

World Psychiatry | January 15, 2026 | Volume: 25 | Issue: 1 | Pages: 158-159

10.1002/wps.70025 | PMID 41536089 Get It